Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-23-001564
Filing Date
2023-06-22
Accepted
2023-06-22 16:47:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422dcth_06222023.htm SC 13G 284611
2 JOINT FILING AGREEMENT ex991to13g07422dcth_06222023.htm EX-99.1 8488
  Complete submission text file 0000921895-23-001564.txt   294785
Mailing Address 1633 BROADWAY SUITE 22C NEW YORK NY 10019
Business Address 1633 BROADWAY SUITE 22C NEW YORK NY 10019 (212) 489-2100
DELCATH SYSTEMS, INC. (Subject) CIK: 0000872912 (see all company filings)

EIN.: 061245881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60851 | Film No.: 231033927
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice